The study of 6,671 individuals found lower rates of self - harm and unintentional injuries among those patients taking lithium compared with
those prescribed valproate, olanzapine or quetiapine.
Not exact matches
The drug — a mood stabilizer called
valproate — is commonly
prescribed to treat bipolar disorder and schizophrenia, though its mechanism of action is poorly understood and only some patients respond to the treatment.
Valproate, one of the most commonly
prescribed antiepileptic medications, has been associated in the past with birth defects and developmental problems.
Joseph F. Hayes, M.Sc., M.B.Ch.B., of University College London, England, and coauthors compared rates of self - harm, unintentional injury and suicide deaths in patients
prescribed lithium,
valproate sodium, olanzapine or quetiapine using a large database of electronic health records in the United Kingdom.
To compare lithium against newer medications, Hayes and his colleagues collected medical data on nearly 6,700 people diagnosed as bipolar and
prescribed only one of the drugs — lithium,
valproate, olanzapine or quetiapine.